About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Detroit | 7,232 Studies Near You

Clinical TrialsDetroit

Clinical Trials in Detroit

Discover 7,232 clinical trials near Detroit, Michigan. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1901-1920 of 7,232 trials

CompletedA Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal MeningitisTo compare the safety and effectiveness of fluconazole and amphotericin B, alone or in combination with flucytosine, as treatment for acute cryptococcal meningitis.NCT00002068·San Francisco, California and 7 others CompletedRNS® System Pivotal StudyThe RNS® System Pivotal study is designed to assess safety and demonstrate that the RNS® System is effective as an adjunctive (add-on) therapy in reducing the frequency of…NCT00264810·Birmingham, Alabama and 31 others

Find Trials by Condition in Detroit

Breast Cancerin Detroit Lung Cancerin Detroit Prostate Cancerin Detroit Colorectal Cancerin Detroit Melanomain Detroit Leukemiain Detroit Lymphomain Detroit Pancreatic Cancerin Detroit Ovarian Cancerin Detroit Brain Cancerin Detroit Diabetes

Data from ClinicalTrials.govTerms

CompletedPhase 2 Study of VX-950, Pegasys®, and Copegus® in Hepatitis CStudy the effectiveness of telaprevir (VX-950) in combination with Pegylated Interferon Alfa 2a (Peg-IFN-alfa-2a) and Ribavirin (RBV) in reducing plasma hepatitis C virus (HCV)…NCT00336479·Phoenix, Arizona and 36 others

CompletedA Study of the Safety and Efficacy of CNTO 888 in Combination With SoC (Standard of Care) Chemotherapy in Patients With Solid TumorsThe purpose of this study is to evaluate the safety and dose regimen of CNTO 888 when administered to patients with solid tumors in combination with 4 standard of care…NCT01204996·Detroit, Michigan and 4 others

Active not recruitingT-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD TrialThis phase III trial compares the effect of usual treatment with trastuzumab emtansine (T-DM1) alone vs. T-DM1 in combination with tucatinib.NCT04457596·Birmingham, Alabama and 1175 others

CompletedA Study of JNJ-67571244 in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)The main purpose of this study are to determine the recommended Phase 2 dose(s) (RP2D) route of administration, schedule and the maximum tolerated dose (MTD) in Part 1 and to…NCT03915379·Boston, Massachusetts and 16 others

CompletedA Study for Participants With Recurrent or Metastatic Squamous Cell Head and Neck CancerThe purpose of this study is to look for an improvement in progression free survival with the combination of pemetrexed, carboplatin (or cisplatin) and cetuximab in participants…NCT01087970·Jonesboro, Arkansas and 20 others

CompletedStudy of a JAK3 Inhibitor for the Prevention of Acute Rejection in Kidney Transplant PatientsA new immunosuppressive drug, based on the inhibition of an important enzyme in the immune system called JAK3, is being developed by Pfizer to prevent transplant rejection.NCT00483756·Little Rock, Arkansas and 68 others

RecruitingA Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine TherapyThis is a Phase III open-label study to assess if camizestrant improves outcomes compared to standard endocrine therapy in patients with ER+/HER2 - early breast cancer with…NCT05774951·Birmingham, Alabama and 708 others

CompletedWeb-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With CancerThis randomized clinical phase III trial studies how well web-based physical activity intervention works in improving long term health in children and adolescents with cancer.NCT03223753·Birmingham, Alabama and 117 others

TerminatedLumiliximab With Fludarabine, Cyclophosphamide, and Rituximab (FCR) Versus FCR Alone in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL)This is a randomized (1:1), open-label, multicenter, active-controlled study in patients with previously treated CD23+ and CD20+ relapsed CLL.NCT00391066·Scottsdale, Arizona and 193 others

CompletedA Study to Evaluate the Safety, Tolerability, and Efficacy of Relatlimab in Relapsed or Refractory B-Cell MalignanciesThe primary objective of this study is to characterize the safety, tolerability, dose-limiting toxicities (DLTs), and maximum tolerated dose (MTD) of relatlimab administered alone…NCT02061761·Baltimore, Maryland and 9 others

Completed3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical ProstatectomyIn April 2011, the United States Food and Drug Administration (FDA) approved the oral drug abiraterone acetate (Zytiga ®) in combination with prednisone (a steroid) to treat…NCT01751451·Chicago, Illinois and 15 others

CompletedAvoiding the Hippocampus During Whole-Brain Radiation Therapy in Treating Patients With Brain MetastasesRATIONALE: Radiation therapy uses high energy x-rays to kill tumor cells.NCT01227954·Birmingham, Alabama and 62 others

TerminatedPF-07284892 in Participants With Advanced Solid TumorsThe purpose of this first-in-patient, open label study is to determine the maximum tolerated dose and/or recommended dose for further study of PF-07284892 as a single agent and in…NCT04800822·Phoenix, Arizona and 10 others

CompletedObservational Study in Cystic Fibrosis Patients Using TOBI® PODHALER® or Other FDA Approved Inhaled Antipseudomonal Antibacterial DrugsThis is a multicenter, prospective, two cohort, observational study over a 5-year period in Cystic Fibrosis (CF) patients with chronic Pseudomonas aeruginosa infection.The study…NCT02449031·Anchorage, Alaska and 46 others

CompletedComputer-Assisted Intervention for Smoking During PregnancyThis study will develop: 1.NCT01028131·Detroit, Michigan

Active not recruitingIsatuximab as Upfront Therapy for the Treatment of High Risk AL AmyloidosisThis phase I trial studies the side effects of isatuximab and to see how well it works in treating patients with high risk immunoglobulin light chain amyloidosis (AL amyloidosis).NCT04754945·Orange, California and 5 others

Active not recruitingStudy of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study)This study will evaluate the efficacy, safety, and pharmacokinetics of tirabrutinib monotherapy in patients with relapsed or refractory PCNSL (Part A), and tirabrutinib in…NCT04947319·Birmingham, Alabama and 38 others

Active not recruitingA Study to Evaluate Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Participants With Childhood EpilepsyThe purpose of the study is to evaluate the efficacy of perampanel as measured by the 50 percent (%) responder rate during the maintenance period of the core study for seizure…NCT04015141·Los Angeles, California and 34 others

PreviousPage 96 of 362Next

in Detroit

Heart Diseasein Detroit